Stay updated on Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updated the location entry from Malmo, Sweden, 20502 to Malmö, Sweden, 20502 to reflect the correct spelling of the city name.
    Difference
    0.0%
    Check dated 2026-05-02T22:56:11.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s revision/version label has been incremented from v3.5.2 to v3.5.3, indicating a site/update release rather than any change to the study information.
    Difference
    0.0%
    Check dated 2026-04-25T16:56:05.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T12:55:17.000Z thumbnail image
  4. Check
    46 days ago
    Change Detected
    Summary
    Revision tag updated: v3.5.0 added and the previous v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-20T20:20:29.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3. Removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T17:49:33.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No visible changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-02-13T12:34:05.000Z thumbnail image

Stay in the know with updates to Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.